| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: Fludarabine versus cyclophosphamide-ATG
|
Kim, Hawk
|
|
2014
|
38 |
7 |
p. 730-736
7 p.
|
artikel
|
| 2 |
Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective—A report by Polish Myeloma Study Group
|
Walter-Croneck, Adam
|
|
2014
|
38 |
7 |
p. 788-794
7 p.
|
artikel
|
| 3 |
Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion
|
Eskazan, Ahmet Emre
|
|
2014
|
38 |
7 |
p. 781-787
7 p.
|
artikel
|
| 4 |
Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat
|
Andersen, Christen Lykkegaard
|
|
2014
|
38 |
7 |
p. 816-821
6 p.
|
artikel
|
| 5 |
Comparison of promoter DNA methylation and expression levels of genes encoding CCAAT/enhancer binding proteins in AML patients
|
Musialik, Ewa
|
|
2014
|
38 |
7 |
p. 850-856
7 p.
|
artikel
|
| 6 |
Dequalinium induces cytotoxicity in human leukemia NB4 cells by downregulation of Raf/MEK/ERK and PI3K/Akt signaling pathways and potentiation of specific inhibitors of these pathways
|
García-Pérez, Ana I.
|
|
2014
|
38 |
7 |
p. 795-803
9 p.
|
artikel
|
| 7 |
Editorial board and publication information
|
|
|
2014
|
38 |
7 |
p. IFC-
1 p.
|
artikel
|
| 8 |
Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia
|
García-Delgado, Regina
|
|
2014
|
38 |
7 |
p. 744-750
7 p.
|
artikel
|
| 9 |
Euchromatic histone methyltransferase 2 inhibitor, BIX-01294, sensitizes human promyelocytic leukemia HL-60 and NB4 cells to growth inhibition and differentiation
|
Savickiene, Jurate
|
|
2014
|
38 |
7 |
p. 822-829
8 p.
|
artikel
|
| 10 |
Large-scale imatinib dose–concentration–effect study in CML patients under routine care conditions
|
Gotta, Verena
|
|
2014
|
38 |
7 |
p. 764-772
9 p.
|
artikel
|
| 11 |
Lenalidomide and metronomic melphalan for CMML and higher risk MDS: A phase 2 clinical study with biomarkers of angiogenesis
|
Buckstein, Rena
|
|
2014
|
38 |
7 |
p. 756-763
8 p.
|
artikel
|
| 12 |
Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphoma
|
Noriega, Victor
|
|
2014
|
38 |
7 |
p. 737-743
7 p.
|
artikel
|
| 13 |
Novel insights into the antiproliferative effects and synergism of quercetin and menadione in human leukemia Jurkat T cells
|
Baran, Irina
|
|
2014
|
38 |
7 |
p. 836-849
14 p.
|
artikel
|
| 14 |
Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: A SEER database analysis
|
Brunner, Andrew M.
|
|
2014
|
38 |
7 |
p. 773-780
8 p.
|
artikel
|
| 15 |
Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine
|
Bally, Cecile
|
|
2014
|
38 |
7 |
p. 751-755
5 p.
|
artikel
|
| 16 |
Screening of a heptamer-type sgRNA library for potential therapeutic agents against hematological malignancies
|
Takahashi, Masayuki
|
|
2014
|
38 |
7 |
p. 808-815
8 p.
|
artikel
|
| 17 |
Telomerase, hTERT and splice variants in patients with myelodysplastic syndromes
|
Dong, Wen
|
|
2014
|
38 |
7 |
p. 830-835
6 p.
|
artikel
|
| 18 |
The GNAS1 gene in myelodysplastic syndromes (MDS)
|
Di Giacomo, Danika
|
|
2014
|
38 |
7 |
p. 804-807
4 p.
|
artikel
|
| 19 |
TP53 mutations and Azacitidine treatment: To be or not to be related?
|
Rigolin, Gian Matteo
|
|
2014
|
38 |
7 |
p. 727-728
2 p.
|
artikel
|
| 20 |
TRUE gene silencing for hematologic malignancies
|
Shivarov, Velizar
|
|
2014
|
38 |
7 |
p. 729-
1 p.
|
artikel
|
Tijdschrift beschrijving